Skip to main content
. 2018 Apr 17;9(29):20539–20554. doi: 10.18632/oncotarget.24993

Figure 3. Evaluation of predictive markers in mCRC patients with k-ras/wt and k-ras/mut who received TSPP vaccine.

Figure 3

Different influence of baseline levels of NLR (A), CRP (B), ENA (C), IFNγ (D), IL12/p70 (E) and IL17/A (F) on k-ras wt and k-ras mut patients treated with TSPP vaccine. Overall survival was compared between the two groups of patients with baseline levels < and ≥ the median value of each specific parameter. Asterisk (*) represents statistical significance between the arms (P < 0.05).